I received my master’s degree in pharmacology from the University Department of Pharmaceutical Sciences (UDPS), R.T.M. Nagpur University, India. During my master’s studies, I worked in Prof. N. K. Subhedar’s Neuroscience Laboratory, where I explored the role of CRF2 receptors in nicotine’s effect on feeding behavior. After completing my master’s, I gained valuable experience in medical affairs and clinical research within the pharmaceutical industry, honing my collaborative research skills in gynecology and infertility. I earned my Ph.D. in neuroscience in Dr. Kartik Nakhate’s lab, focusing on the therapeutic potential of apple peel extract and its key component, phloridzin, in mitigating diabetes-related neurological complications. Following my Ph.D., I worked at Lupin Pharmaceuticals Ltd., a global pharmaceuticals company, where I was recognized with the Best Brand Plan Award and Star Awards for my contribution. Currently, I am a postdoctoral fellow in Dr. Whitney Parker’s lab at the University of Maryland, Baltimore. My research focuses on developing innovative treatments for temporal lobe epilepsy (TLE), specifically investigating low-intensity focused ultrasound (LOFU) as a minimally invasive approach to prevent epilepsy progression and shift treatment paradigms from reactive to preventive care. This work has earned me prestigious honors, including the Grass Foundation Young Investigator Award (AES, 2024) and the Baltimore Brain Series Award (Johns Hopkins, 2024).

In my free time, I enjoy listening to music, singing, cooking, and spending time with my children, Arjun and Vedha.